Rainier Acquisition Corporation operates as a blank check company formed for the purpose of effecting a merger, acquisition, or similar business combination. The company intends to focus its search on the global life sciences industries, including therapeutics, diagnostics, genomics, precision medicine, life science tools, and research services.
| Price | $10.14 |
|---|---|
| Market cap | $87.46M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| 52-week range | 10-10.5 |
| Beta | 0 |
Explore RNAQ's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.